Publication | Closed Access
Durable inhibition of hepatitis B virus replication and antigenemia using a subcutaneously administered siRNA agent in preclinical models
10
Citations
0
References
2018
Year
Viral ReplicationHepatologySirna AgentViral HepatitisPreclinical ModelsMedicineImmunologyHepatitis BHepatitisVirologyDurable InhibitionAntiviral Drug DevelopmentAntiviral TherapyAntiviral DrugPharmacology
No additional data available for this publication yet. Check back later!